ELAN
Elanco Animal Health
22.90$
+1.7%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 24.9% | 23.7% | 28.9% | 29.1% | 25.3% | 25.5% | 26.6% | 26.3% | 25.8% | 25.9% | 27.1% | 28.0% | |
| 2.6% | 2.5% | 2.5% | 3.0% | 3.7% | 3.7% | 3.8% | 3.9% | 3.7% | 4.1% | 3.2% | 3.9% | |
| 2.6% | 2.5% | 2.5% | 3.0% | 3.7% | 3.7% | 3.8% | 3.9% | 3.7% | 4.1% | 3.2% | 3.9% | |
| 7.9% | 7.0% | 7.7% | 7.8% | 6.8% | 7.0% | 8.2% | 8.0% | 7.2% | 7.0% | 8.7% | 8.5% | |
| 11.8% | 12.1% | 11.7% | 11.7% | 12.3% | 12.5% | 12.3% | 12.2% | 12.6% | 13.0% | 13.0% | 13.0% | |
| 6.9% | – | – | – | – | – | – | – | – | – | – | – | |
| 34.2% | 35.5% | 31.9% | 32.5% | 34.8% | 35.0% | 34.8% | 34.6% | 35.2% | 35.8% | 35.7% | 35.7% | |
| 31.2% | 31.3% | 29.9% | 29.1% | 30.2% | 29.2% | 28.1% | 27.0% | 26.5% | 25.5% | 24.4% | 23.6% | |
| 57.2% | 56.7% | 56.8% | 56.8% | 50.9% | 51.7% | 50.9% | 50.7% | 50.2% | 51.0% | 50.8% | 51.4% | |
| 8.8% | 8.6% | 8.8% | 10.0% | 9.9% | 10.4% | 9.8% | 10.1% | 10.7% | 12.0% | 12.6% | 13.7% | |
| 0.3% | 0.3% | 0.3% | 1.5% | 0.3% | 0.3% | 0.3% | 0.4% | 0.5% | 0.6% | 0.6% | 0.5% | |
| 2.1% | 1.9% | 2.2% | 2.1% | 1.9% | 2.3% | 2.6% | 2.7% | 2.6% | 2.8% | 2.8% | 3.1% | |
| 40.9% | 39.9% | 40.9% | 39.7% | 32.5% | 33.9% | 33.6% | 30.2% | 29.2% | 29.5% | 29.6% | 28.4% | |
| 42.8% | 43.3% | 43.2% | 43.2% | 49.1% | 48.3% | 49.1% | 49.3% | 49.8% | 49.0% | 49.2% | 48.6% | |
| -15.0% | -15.9% | -16.1% | -16.8% | -14.6% | -15.5% | -14.6% | -13.6% | -14.1% | -16.3% | -16.1% | -15.3% | |
| 3.4% | 3.4% | 3.5% | 3.6% | 3.7% | 3.9% | 3.9% | 3.6% | 3.7% | 3.7% | 3.8% | 3.7% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.